Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A cysteine prodrug is a compound designed to deliver cysteine or its functional benefits in a controlled manner, often to overcome limitations such as poor bioavailability, instability, or inability to cross biological barriers like the blood-brain barrier (BBB). These prodrugs are typically engineered so that they release active cysteine (or related molecules) at the target site through enzymatic or chemical processes. They are utilized to enhance glutathione levels, provide antioxidant effects, or facilitate targeted drug delivery, particularly in conditions like neurodegenerative diseases, acetaminophen overdose, and cancer.
Release of cysteine or cysteine-related molecules through chemical or enzymatic processes, leading to increased glutathione levels, antioxidant effects, or targeted drug delivery.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine Prodrug (N/A).